Clinical trial
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
NCT00012246 · The University of Texas Medical Branch, Galveston, Other · Terminated
Key facts
| NCT number | NCT00012246 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract |
| Official title | A Trial Of Vaccination With The Carcinoembryonic Antigen (CEA) Peptide Cap 1-6D With Montanide ISA 51 Adjuvant Or Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) In HLA-A2+ Patients With CEA Producing Adenocarcinomas Of Gastrointestinal (GI) Tract Origin |
| Lead sponsor | The University of Texas Medical Branch, Galveston, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine Cancer |
| Intervention type | Biological |
| Interventions | carcinoembryonic antigen peptide 1-6D, incomplete Freund's adjuvant, sargramostim |
| Enrollment | 7 |
| Start date | Jul 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | May 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: